Erik A. Sistermans

11.7k total citations · 1 hit paper
123 papers, 5.6k citations indexed

About

Erik A. Sistermans is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erik A. Sistermans has authored 123 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 53 papers in Molecular Biology and 38 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erik A. Sistermans's work include Prenatal Screening and Diagnostics (37 papers), Genomic variations and chromosomal abnormalities (30 papers) and Fetal and Pediatric Neurological Disorders (21 papers). Erik A. Sistermans is often cited by papers focused on Prenatal Screening and Diagnostics (37 papers), Genomic variations and chromosomal abnormalities (30 papers) and Fetal and Pediatric Neurological Disorders (21 papers). Erik A. Sistermans collaborates with scholars based in Netherlands, United States and United Kingdom. Erik A. Sistermans's co-authors include Bert B.A. de Vries, Willy M. Nillesen, Ilse J. de Wijs, David A. Koolen, Nicole de Leeuw, Marjan M. Weiss, Rolph Pfundt, Marcel Reinders, Roy Straver and Cees B.M. Oudejans and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Erik A. Sistermans

120 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline KRAS mutations cause Noonan syndrome

2006 514 citations Erik A. Sistermans et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik A. Sistermans Netherlands	37	2.9k	2.7k	1.0k	518	475	123	5.6k
Rolph Pfundt Netherlands	42	2.6k 0.9×	2.9k 1.1×	586 0.6×	520 1.0×	436 0.9×	136	5.2k
Ankita Patel United States	42	2.8k 1.0×	4.1k 1.5×	1.7k 1.6×	744 1.4×	313 0.7×	143	6.5k
Dominique Smeets Netherlands	38	2.6k 0.9×	2.7k 1.0×	824 0.8×	776 1.5×	658 1.4×	112	4.9k
Lidia Larizza Italy	43	3.7k 1.3×	2.3k 0.9×	780 0.8×	407 0.8×	573 1.2×	271	6.3k
Helen V. Firth United Kingdom	38	3.1k 1.1×	4.5k 1.6×	1.1k 1.1×	420 0.8×	679 1.4×	102	6.7k
Betsy Hirsch United States	42	3.4k 1.2×	2.4k 0.9×	754 0.7×	302 0.6×	735 1.5×	179	7.3k
Joan H.M. Knoll United States	37	5.0k 1.8×	4.0k 1.5×	1.6k 1.5×	358 0.7×	650 1.4×	107	8.1k
Lisenka E.L.M. Vissers Netherlands	39	3.6k 1.3×	5.1k 1.9×	943 0.9×	790 1.5×	586 1.2×	98	7.7k
Anita Rauch Germany	48	4.4k 1.5×	3.4k 1.3×	679 0.7×	459 0.9×	332 0.7×	194	7.5k
Joseph Glessner United States	39	2.2k 0.8×	3.4k 1.3×	426 0.4×	353 0.7×	623 1.3×	138	5.5k

Countries citing papers authored by Erik A. Sistermans

Since Specialization

Citations

This map shows the geographic impact of Erik A. Sistermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Sistermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Sistermans more than expected).

Fields of papers citing papers by Erik A. Sistermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Sistermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Sistermans. The network helps show where Erik A. Sistermans may publish in the future.

Co-authorship network of co-authors of Erik A. Sistermans

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Sistermans. A scholar is included among the top collaborators of Erik A. Sistermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Sistermans. Erik A. Sistermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faas, Brigitte H. W., Galuh Astuti, A. Reuss, et al.. (2025). Detection of human cytomegalovirus cell‐free DNA in pregnant women with symptomatically infected fetuses: proof‐of‐concept study. Ultrasound in Obstetrics and Gynecology. 65(4). 470–477. 3 indexed citations

Sistermans, Erik A., Hugo M. Horlings, Constantijne H. Mom, et al.. (2024). Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass. International Journal of Gynecological Cancer. 34(5). 713–721. 3 indexed citations

Srebniak, Malgorzata I., et al.. (2024). Implementing non-invasive prenatal testing in a national screening program: Lessons learned from the TRIDENT studies. Best Practice & Research Clinical Obstetrics & Gynaecology. 97. 102543–102543. 1 indexed citations

Schuit, Ewoud, et al.. (2023). Association between low fetal fraction in cell‐free DNA screening and fetal chromosomal aberrations: A systematic review and meta‐analysis. Prenatal Diagnosis. 43(7). 838–853. 4 indexed citations

Scheffer, P, Jens Henrichs, Caroline J. Bax, et al.. (2023). Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women. American Journal of Obstetrics and Gynecology. 231(2). 244.e1–244.e18. 10 indexed citations

Brink, Arjen, et al.. (2023). In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region. The CRISPR Journal. 6(2). 127–139. 12 indexed citations

Meij, Karuna R. M. van der, Mireille N. Bekker, Linda Martin, et al.. (2022). Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program. European Journal of Human Genetics. 31(5). 555–561. 12 indexed citations

Welkers, Matthijs R. A., et al.. (2022). The cell‐free DNA virome of 108,349 Dutch pregnant women. Prenatal Diagnosis. 43(4). 448–456. 16 indexed citations

Meij, Karuna R. M. van der, Lidewij Henneman, & Erik A. Sistermans. (2022). Non‐invasive prenatal testing for everybody or contingent screening?. Prenatal Diagnosis. 43(4). 443–447. 5 indexed citations

10.

Meij, Karuna R. M. van der, Ellen W. S. Carbo, Wendy Rodenburg, et al.. (2021). Uptake of fetal aneuploidy screening after the introduction of the non‐invasive prenatal test: A national population‐based register study. Acta Obstetricia Et Gynecologica Scandinavica. 100(7). 1265–1272. 30 indexed citations

11.

Palomaki, Glenn E., Rossa W. K. Chiu, Mark D. Pertile, et al.. (2020). International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies. Prenatal Diagnosis. 41(10). 1222–1232. 41 indexed citations

12.

Cohn‐Hokke, Petra E., Henne Holstege, Marjan M. Weiss, et al.. (2016). A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 174(3). 220–226. 4 indexed citations

13.

Oepkes, Dick, Godelieve C.M.L. Page‐Christiaens, Caroline J. Bax, et al.. (2016). Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact. Prenatal Diagnosis. 36(12). 1083–1090. 110 indexed citations

14.

Koolen, David A., Rolph Pfundt, Nicole de Leeuw, et al.. (2008). Genomic microarrays in mental retardation: A practical workflow for diagnostic applications. Human Mutation. 30(3). 283–292. 103 indexed citations

15.

Koolen, David A., Rolph Pfundt, Nicole de Leeuw, et al.. (2006). A novel 2.3 Mb microduplication of 12q24.21q24.23 detected by genome-wide tiling-path resolution array comparative genomic hybridization in a girl with syndromic mental retardation. Clinical Dysmorphology. 15(3). 133–137. 7 indexed citations

16.

Ramsden, Simon, Zandra C. Deans, David Robinson, et al.. (2006). Monitoring Standards for Molecular Genetic Testing in the United Kingdom, The Netherlands, and Ireland. Genetic Testing. 10(3). 147–156. 27 indexed citations

17.

Lange, Marcos Christiano, Viviane Flumignan Zétola, Hélio Afonso Ghizoni Teive, et al.. (2004). Cerebrotendinous xanthomatosis: report of two Brazilian brothers. Arquivos de Neuro-Psiquiatria. 62(4). 1085–1089. 8 indexed citations

18.

Kleefstra, Tjitske, Helger G. Yntema, Willy M. Nillesen, et al.. (2003). MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. European Journal of Human Genetics. 12(1). 24–28. 37 indexed citations

19.

Sistermans, Erik A., et al.. (1999). Gene symbol: PLP. Disease: Pelizaeus-Merzbacher disease.. Human Genetics. 104. 195–195. 2 indexed citations

20.

Sistermans, Erik A., et al.. (1995). Tissue- and cell-specific distribution of creatine kinase B: A new and highly specific monoclonal antibody for use in immunohistochemistry. Cell and Tissue Research. 280(2). 435–446. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact